Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Edward Smith

Orthopaedic Surgery of the Spine Meridian, MS Medical Doctor

NPI 1497199020 CMS profile 1377317

5002 Highway 39 N Bldg C, Meridian, MS 39301

Open in the dashboard

General payments

$258,640

147 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Edward Smith of Meridian, MS is reported in the CMS Open Payments database as having received $258,640 across 147 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 86th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $151,144 30
2024 General $49,687 11
2023 General $18,329 16
2022 General $16,566 20
2021 General $11,086 3
2020 General $3,050 5
2019 General $8,779 62

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Edward Smith
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Edward Smith were reported at $151,144. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Edward Smith Orthopaedic Surgery of the Spine median Middle half National median
2019 $8,779 $2,106 $337–$18,608 $163
2020 $3,050 $1,213 $156–$15,082 $114
2021 $11,086 $1,834 $271–$15,617 $132
2022 $16,566 $2,015 $320–$17,036 $149
2023 $18,329 $1,925 $336–$14,599 $160
2024 $49,687 $2,110 $341–$12,483 $164
2025 $151,144 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Genesys Orthopedics Systems, L.L.C. $131,998 7 payments
  2. Zavation LLC $82,165 16 payments
  3. SurGenTec $15,500 4 payments
  4. Osseus Fusion Systems, LLC $13,632 10 payments
  5. Spineart USA Inc $10,085 38 payments
  6. Stryker Corporation $3,529 52 payments
  7. Medacta USA, Inc. $636 1 payment
  8. Republic Spine, LLC $361 3 payments
  9. 4WEB, Inc. $196 2 payments
  10. DePuy Synthes Sales Inc. $162 2 payments
  11. Other $377 12 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $238,750 28 payments
  2. Travel and Lodging $9,366 13 payments
  3. Food and Beverage $6,819 102 payments
  4. Royalty or License $3,177 2 payments
  5. Education $375 1 payment
  6. Entertainment $153 1 payment
Products named General payments · program years 2019–2025
  1. Graftgun Universal Graft Delivery System $11,000 1 payment
  2. ALARA Access Needle $11,000 1 payment
  3. Zavation $6,000 1 payment
  4. Hydroputty $2,000 1 payment
  5. Alara $2,000 1 payment
  6. TRITANIUM $1,557 14 payments
  7. ES2 $1,214 6 payments
  8. PERLA TL $834 8 payments
  9. SCARLET AL-T $796 8 payments
  10. SERRATO $702 7 payments
  11. Other $4,588 73 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 14 drugs

Part D claims

1,279

Median for Orthopedic Surgery: 203

Drug cost

$61,561

Median for Orthopedic Surgery: $1,433

Branded share of claims

5.2%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Daptomycin Generic 12 $45,784
Gabapentin Generic 679 $9,261
Pregabalin Generic 95 $1,359
Cyclobenzaprine Hcl Generic 176 $1,138
Duloxetine Hcl Generic 61 $1,132
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 66 $762
Amitriptyline Hcl Generic 67 $686
Baclofen Generic 20 $383
Promethazine Hcl Generic 30 $286
Tizanidine Hcl Generic 22 $270

The 10 drugs with the highest cost, of 14 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 69 billing codes

Paid by Medicare

$149,685

Medicare's payments for the services billed

Medicare patients

369

Average age 73

Services billed

1,443

215 women, 154 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 42%
Depression 33%
Chronic kidney disease 31%
Ischemic heart disease 29%
COPD 23%
Heart failure 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

147 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in Mississippi

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record